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A B S T R A C T
No effective, reliable treatment for stomatitis associated with cancer therapy has been established. This study
focused on the its effectiveness of ozone nano-bubble water (ONBW) for the treatment of chemotherapy-induced
stomatitis. Oral mucositis was induced in 14-week-old male Sprague-Dawley rats (N=21). The animals were
randomly divided into 3 groups: 7 without treatment (control); 7 treated with physiological salt solution (saline);
and 7 treated with ONBW. Animals were weighed on Days 7, 9, 11, and 16. Stomatitis grade evaluation and
bacterial count measurements were performed before rinsing in all animals 3, 5, and 10 days after acetic acid
irritation (Days 9, 11, and 17 respectively). Weight loss after stomatitis creation was observed in all groups, with
significant differences between the control and ONBW groups and between the saline and ONBW groups on Day
16. The stomatitis grade did not worsen during the experimental period in any group, with the lowest grades in
the ONBW group on Days 11 and 16. Significant differences were identified between the control and ONBW
groups and between the saline and ONBW groups on Days 11 and 16. Oral bacterial counts tended to decrease
over time in all three groups, with the greatest decrease in the ONBW group, followed by the saline group. The
decrease in the bacterial count was steepest in the ONBW group. Rinsing out the oral cavity with ONBW de-
creased bacterial counts and encouraged the healing of oral chemotherapy-induced stomatitis. ONBW may be an
effective treatment for chemotherapy-induced stomatitis.
1. Introduction
Cancer treatment has made great strides with the development of
new anticancer agents and combination radiotherapy protocols [1].
Compared with the development of therapies for primary disease,
however, the development of treatments for the side effects associated
with these therapies is lagging [2]. It has been reported that oral mu-
cositis is a common side effect in patients receiving anticancer agents,
with an incidence of 25%–55% in patients receiving anticancer agents
for solid cancer, 70%–90% in those receiving high-dose anticancer
agents for hematopoietic stem cell transplantation, and almost 100%
among patients receiving anticancer agents and radiotherapy of the
head and neck [1,3,4]. The pain of stomatitis causes masticatory and
swallowing problems that lead to poor nutrition, reducing patients’
quality of life (QOL) and making them more susceptible to infection
[5]. Stomatitis is not only a dose-limiting factor [6], but it is also known
to increase infection-related mortality [7], and it may necessitate the
withdrawal of cancer treatment or changes to the treatment plan [8].
In general, the etiology of chemotherapy-induced stomatitis can be
broadly divided into two main causes. One primary cause is mucosal
inflammation due to the destruction of the cells that compose the oral
mucosa by reactive oxygen species (superoxide or hydroxy radicals)
generated by anticancer agents. Cells in the oral mucosa also undergo
metabolic damage as a result of their uptake of anticancer agents,
blocking healthy oral mucosal cell turnover. The secondary cause is the
adhesion of high levels of oral bacteria to the ulcerated surface, causing
local infection on the mucosal surface, and, in combination with the
metabolic damage and susceptibility to infection caused by anticancer
agents, this can become intractable or serious [9,10]. Stomatitis is being
studied using a range of different animal models [11], but the detailed
etiology of chemotherapy-induced stomatitis is unknown and may in
fact be more complex [12–14].
As yet, no studies of stomatitis associated with cancer treatment
with a high evidence level have been published, and an effective, re-
liable method of treatment has yet to be established [15,16]. There is a
need for the development of a treatment method for chemotherapy-
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induced stomatitis to enable the completion of high-quality cancer
treatment.
This study focused on ozone nano-bubble water (ONBW) [20,21],
which has previously been shown to have a range of effects, including
antibacterial effects [17], promotion of wound healing [18], an anti-
inflammatory effect [18], and a hemostatic effect [19], and its effec-
tiveness in the treatment of chemotherapy-induced stomatitis was in-
vestigated.
2. Materials and methods
2.1. Ozone nano-bubble water
Ozone nano-bubble water (REO Institute, Inc, Sendai, Japan) was
generated using the production method described by Kamiyama [20].
Micro-bubbles with a diameter of less than 50 μm were generated in
hard water (underground water) at a salinity of 0.9 mass%. The micro-
bubbles were then rapidly crushed into bubbles with a diameter of less
than 200 nm for use as the ONBW in this study.
2.2. Animals
All of the procedures performed with live animals conformed to the
ethical guidelines established by the Japanese Council on Animal Care
and were approved by the animal care committee of the Tokyo Dental
College (Permit Number: 282403). Fourteen-week-old male Sprague-
Dawley rats (N=21) were obtained from Sankyo Laboratory (Tokyo,
Japan). All animals were housed in a room maintained under standar-
dized light (12:12 h light-dark cycle), temperature (23 ± 2 °C), and
humidity (55% ± 5%) conditions with free access to food pellets and
drinking water.
2.3. An animal model for mucositis induced by cancer chemotherapy
The protocol for the induction of oral mucositis was modified on the
basis of a previously published protocol [22,23]. All rats received in-
traperitoneal administration of 5-FU (Wako Pure Chemical Industries
Ltd, Osaka, Japan) (60mg/kg/day) on Days 1, 2, 3, 4, and 5. On Day 6,
after anesthesia induction with 4% sevoflurane (Maruishi Pharmaceu-
tical Co., Ltd., Osaka, Japan) inhalation, the rats were further an-
esthetized by intraperitoneal injection with sodium pentobarbital
(30mg/kg body weight Somnopentyl; Kyoritsu Seiyaku, Tokyo, Japan),
and 100% acetic acid (Wako Pure Chemical Industries Ltd, Osaka,
Japan) 50 μl was painted onto the lingual dorsum with a Plaut brush®
(Oral Care. Ltd, Tokyo, Japan) and rubbed in to produce stomatitis. The
animals were randomly divided into 3 groups: 7 without treatment as
the control animals, 7 treated with physiological salt solution (saline),
and 7 treated with ONBW.
After stomatitis creation, the animals’ mouths were rinsed four
times daily (every 6 h) with physiological saline in the saline group and
with ONBW in the ONBW group, while the mouths of the control group
were left untouched. Rinsing was carried out using a Doltz EW1211®
(Panasonic Healthcare, Tokyo, Japan) at a water pressure of 4.0 kgf/
cm2.
All animals were weighed on Days 7, 9, 11, and 16.
Stomatitis grade evaluation and bacterial count measurements were
also carried out before rinsing in all animals 3, 5, and 10 days after
acetic acid irritation (Days 9, 11, and 17 respectively) (Fig. 1).
2.4. Stomatitis grading
The National Cancer Institute-Common Terminology Criteria for
Adverse Events (NCI-CTCAE) evaluation criteria for oral mucositis [24]
were modified to produce criteria for grading chemotherapy-induced
oral mucositis in rats for this study (Fig. 2). Stomatitis grading using
these criteria was carried out before rinsing 3, 5, and 10 days after
acetic acid irritation (Days 9, 11, and 17 respectively).
2.5. Criteria for oral mucositis induced by cancer chemotherapy in rats
Grade 0: Normal mucosa.
Grade 1: Redness of the mucosa with punctate ulcers or pseudo-
membrane.
Grade 2: Confluent ulceration or pseudomembrane, no bleeding on
slight stimulation.
Grade 3: Confluent ulceration or pseudomembrane, bleeding on
slight stimulation.
Grade 4: Tissue necrosis or spontaneous bleeding.
2.6. Oral bacterial count measurement
Oral bacterial count measurement was carried out prior to rinsing 3,
5, and 10 days after acetic acid irritation (Days 9, 11, and 17 respec-
tively). Bacteria in the oral cavity were measured in a standardized way
based on a previous study. The amount of bacteria on the following
places in the oral cavity was measured by a bacteria detection appa-
ratus [25] (Panasonic Healthcare, Tokyo, Japan). Briefly, a sterilized
swab was pressed on the sampling area and rubbed backwards and
forwards three times along the center of the lingual dorsum from the
lingual apex to the lingual root with a constant force of 20 g using a
device on the bacteria detection apparatus. The swab was swiped on the
applicable areas three times in a 10-mm swath. The swab was then
placed in distilled water in the bacteria detection apparatus for
counting. Bacteria quantification was performed using the dielec-
trophoretic impedance measurement technique [26,27].
2.7. Statistical analyses
The distributions of weight (g) on Day 6 and bacterial count
(× 105 cfu/ml) on Day 9 were tested for normality using the Shapiro-
Wilk test. If the normality test showed a significant difference, non-
parametric methods were used, and if no significant difference was
found, parametric methods were applied.
Basic statistics for weight and stomatitis grading were calculated for
each group, and differences between groups and time points were
compared using non-parametric methods. Differences among all three
groups were investigated using the Kruskal-Wallis test, and compar-
isons between two groups were made using the Mann-Whitney U test,
with p values adjusted using a non-parametric version of Tukey's
method (Steel-Dwass test).
Basic statistics for oral bacterial counts were calculated for each
group, and differences between groups and time points were compared
using parametric methods. Differences among all three groups were
investigated using analysis of variance (ANOVA), and comparisons
between two groups were made using the t-test, with p values adjusted
using Tukey's method.
SAS 9.4 statistical software (SAS Institute Inc., Cary, NC, USA) was




The Shapiro-Wilk tests for normality of the distributions of weight
(g) on Day 6 and bacterial count (× 105 cfu/ml) on Day 9 showed a
significant difference for weight, but not for bacterial count.
Weight: p= 0.0052.
Bacterial count: p= 0.7728.
K. Hayashi, et al. Biochemistry and Biophysics Reports 20 (2019) 100697
2
3.2. Evaluation of weight changes
Weight loss after stomatitis creation was observed in all groups.
Weight was lowest on Day 9, and no great change was seen on Day 11,
but by Day 16 it had started to increase again.
Basic statistics for weight were calculated for each group, and dif-
ferences between groups and time points were compared using non-
parametric methods. Differences among all three groups were in-
vestigated using the Kruskal-Wallis test, and comparisons between two
groups were made using the Mann-Whitney U test, with p values ad-
justed using a non-parametric version of Tukey's method (Steel-Dwass
test).
Significant differences were identified between the control and
ONBW groups and between the saline and OBNW groups on Day 16
(p < 0.05).
3.3. Stomatitis grading
The stomatitis grade did not worsen during the experimental period
in any of the groups. The lowest grades were seen in the OBNW group
on Days 11 and 16. In the control group, there was no improvement in
grade during the experimental period. In the saline group, there was no
great change on Day 11, but the grade improved on Day 16. In the
ONBW group, the grade improved on both Day 11 and Day 16, with an
overall improvement in grade over time.
Significant differences were identified between the control and
ONBW groups and between the saline and OBNW groups on Days 11
and 16 (Fig. 3).
3.4. Oral bacterial count measurements
Oral bacterial counts tended to decline over time in all three groups.
The greatest decrease was seen in the ONBW group, followed by the
saline group. The decline in the bacterial count was steepest in the
ONBW group.
Significant differences were identified between the control and
OBNW groups and between the saline and OBNW groups on Days 9, 11,
and 16 (Fig. 4).
4. Discussion
The cortical layer of the oral mucosa is covered with stratified
squamous epithelium, below which lies fibrous connective tissue con-
taining a large number of capillary vessels. Wound healing in the oral
mucosa follows a process of vasoconstriction, blood clot formation, fi-
brin formation, inflammatory cell infiltration, cell proliferation, neo-
vascularization, and epithelial regeneration. Local factors affecting this
healing process include insufficient oxygen supply, local infection, and
the presence of foreign bodies. Systemic factors that may also have an
effect include age, sex, circulatory impairment, immunocompromised
status, nutritional status, systemic disease, and use of concomitant
medications such as steroids and anticancer agents [28]. Sonis [10]
found that local mucosal infection by oral resident bacteria is an ag-
gravating factor in chemotherapy-induced stomatitis, and the im-
portance of oral care has become a focus in ensuring that cancer pa-
tients can complete good-quality therapy. One characteristic of
chemotherapy-induced stomatitis is the adhesion of high levels of oral
bacteria to the ulcerated surface, causing local infection of the mucosal
surface, where the bacteria become established and flourish. In com-
bination with the metabolic damage and susceptibility to infection
caused by anticancer agents, this can become intractable or serious
[9,10]. Local infection thus delays the healing of stomatitis, and the
delayed healing of stomatitis also increases susceptibility to infection.
In chemotherapy-induced stomatitis, local infection and delayed
healing of stomatitis act synergistically to bring about critical coloni-
zation [29]. Reducing the bacterial count is important to improve cri-
tical colonization, and this can be achieved by chemical removal with
pharmaceutical agents or physical removal by rinsing or similar
Fig. 1. Experimental protocol.
5-FU (60mg/kg/day) was administered on Days 1, 2,
3, 4, and 5. On Day 6, 100% acetic acid 50 μl was
painted onto the lingual dorsum to irritate it and
produce stomatitis. After stomatitis creation (Day 6),
rinsing was carried out using a Doltz EW1211®
(Panasonic Healthcare, Tokyo, Japan) at a water
pressure of 4.0 kgf/cm2 four times daily until Day 16.
Stomatitis grading and bacterial count measurement
were carried out prior to rinsing 3, 5, and 10 days
after acetic acid irritation (Days 9, 11, and 17 re-
spectively).
Fig. 2. Rat chemotherapy-induced stoma-
titis grading criteria.
Grade 0: Normal mucosa
Grade 1: Redness of the mucosa with
punctate ulcers or pseudomembrane
Grade 2: Confluent ulceration or pseudo-
membrane, no bleeding on slight stimula-
tion
Grade 3: Confluent ulceration or pseudo-
membrane, bleeding on slight stimulation.
Grade 4: Tissue necrosis or spontaneous
bleeding.
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methods. Although animal models of chemotherapy-induced stomatitis
have previously been reported [11], no previous study has addressed
the association between the healing of chemotherapy-induced stoma-
titis and bacterial count.
There are two reasons that critical colonization occurs in che-
motherapy-induced stomatitis. The first is the presence of large num-
bers of resident bacteria in the mouth, in addition to the fact that the
oral mucosa is constantly covered with mucus. The second is that, in
stomatitis, the ulcerated surfaces are covered with necrotic material,
which offers a breeding ground for bacteria and creates an environment
in which they can easily become established. The fact that the ulcerated
surface is covered in mucus and necrotic material is believed to weaken
the effect of pharmaceutical agents [30–33]. In the present study, the
bacterial counts in both the saline and OBNW groups decreased com-
pared with the control group. This may have been because of the re-
moval of mucosal substances and necrotic material by the water pres-
sure generated during rinsing with the Doltz EW1211, which exerted a
mechanical cleaning effect [34].
Previous studies have described the excellent antibacterial effect of
ONBW [7,21,35]. Unlike antibiotics, ONBW has the advantage that it
does not risk the potential emergence of drug-resistant bacteria [36]. In
the present study, the bacterial count decreased markedly in the ONBW
group, suggesting that it may have exerted an antibacterial effect on the
bacteria on the mucosal surface in the chemotherapy-induced stoma-
titis. However, in the present study, which bacterial strains were pre-
sent in chemotherapy-induced stomatitis, or which strains were af-
fected to what extent by the antibacterial effect of ONBW were not
investigated, and further investigation of these questions is required.
There was no significant difference among the three groups in the
weight changes on Days 9 and 11, and no difference in the amount
eaten was observed. After stomatitis developed, the amount eaten by
the animals decreased, causing them to lose weight. This may have
been because of the pain during eating associated with stomatitis. On
Day 16, the weight of the animals in the ONBW group increased sig-
nificantly compared with the control and saline groups, which may
have been because they were eating more as the stomatitis had healed,
meaning that they were suffering less pain. It was considered unlikely
that ONBW had had an analgesic effect on the pain during eating
caused by stomatitis.
There was no increase in stomatitis grade during the experimental
period, and the grade tended to decrease over time. No side effects or
other adverse events occurred in the ONBW group during the experi-
mental period, suggesting that ONBW does not cause any biological
damage, but more in-depth in vivo studies at the cellular molecular level
Fig. 3. Stomatitis grading.
The stomatitis grade did not worsen during the ex-
perimental period in any of the groups. The lowest
grades are seen in the OBNW group on Days 11 and
16. In the control group, there is no improvement in
grade during the experimental period. In the saline
group, there is no great change on Day 11, but the
grade improves on Day 16. In the ONBW group, the
grade improves on both Day 11 and Day 16, with an
overall improvement in grade over time.
Basic statistics for stomatitis grading were calculated
for each group, and differences between groups and
time points were compared using non-parametric
methods. Differences between all three groups were
investigated using the Kruskal-Wallis test, and com-
parisons between two groups were made using the
Mann-Whitney U
test, with p values adjusted using a non-parametric
version of Tukey's method (Steel-Dwass test).
Significant differences were identified between the
control and ONBW groups and between the saline
and OBNW groups on Days 11 and 16 (p < 0.5).*:
p < 0.05.
Fig. 4. Oral bacterial count measurements.
The oral bacterial count tends to decline over time in
all three groups. The greatest decrease is seen in the
ONBW group, followed by the saline group. The
steepest decline in bacterial count is seen in the
ONBW group. Basic statistics for oral bacterial count
were calculated for each group, and differences be-
tween groups and time points were compared using
parametric methods. Differences among all three
groups were investigated using analysis of variance
(ANOVA), and comparisons between two groups
were made using the t-test, with p values adjusted
using Tukey's method. Significant differences are
seen between the control and OBNW groups and
between the saline and OBNW groups on Days 9, 11,
and 16 (p < 0.5).*: p < 0.05.
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are required.
The MASCC/ISOO Evidence Based Clinical Practice Guidelines for
Mucositis Secondary to Cancer Therapy suggest oral care, oral cryo-
therapy, low-level laser therapy, benzydamine mouthwash, and the use
of recombinant human Keratinocyte Growth Factor-1 (KGF-1) as sup-
portive therapies for preventing stomatitis associated with cancer
treatment [37]. As yet, however, no studies of stomatitis associated
with cancer treatment with a high evidence level have been published,
and an effective, reliable, and biologically safe method of treatment has
yet to be established [15,16,37]. The results of the present study sug-
gest that ONBWmay exert a strong antibacterial effect while causing no
biological damage, promoting the healing of chemotherapy-induced
stomatitis. Although more detailed investigations are required of the
bacterial strains targeted by ONBW, a potential harmful effect at the
cellular level, and its use in conjunction with a variety of different
anticancer agents, the present results suggest that ONBW may be an
effective treatment for chemotherapy-induced stomatitis.
5. Conclusions
The efficacy of ONBW for treating chemotherapy-induced stomatitis
was investigated in a rat model. ONBW caused no biological harm and
showed a strong antibacterial effect.
Rinsing out the oral cavity with ONBW decreased bacterial counts
and encouraged the healing of oral chemotherapy-induced stomatitis.
The present results suggest that ONBW may be an effective treat-
ment for chemotherapy-induced stomatitis in the future.
Funding
This research did not receive any specific grant from funding
agencies in the public, commercial, or not-for-profit sectors.
Declaration of competing interest
The authors declare no conflicts of interest associated with this
manuscript.
Acknowledgments
The authors are grateful to Kaneo Chiba, President and CEO of REO
Institute, Inc, Sendai, Japan, for providing the ONBW.
References
[1] B.A. Chabner, D.L. Longo, Cancer Chemotherapy and Biotherapy: Principles and
Practice, fourth ed., Lippincott Williams and Wilkins, Philadelphia, 2006.
[2] National Cancer Institute website, http://www.cancer.gov/cancertopics/pdq/
supportivecare/oralcomplications/HealthProfessional , Accessed date: 20
November 2018.
[3] D.E. Peterson, New strategies for management of oral mucositis in cancer patients,
J. Support. Oncol. 4 (2006) 9–13.
[4] M.U. Naidu, G.V. Ramana, P.U. Rani, et al., Chemotherapy – induced and/or ra-
diation therapy – induced oral mucositis. Complicating the treatment of cancer,
Neoplasia 6 (2004) 423–431.
[5] E.B. Rubenstein, D.E. Peterson, M. Schubert, et al., Clinical practice guidelines for
the prevention and treatment of cancer therapy-induced oral and gastrointestinal
mucositis, Cancer 100 (2004) 2026–2046.
[6] L.S. Elting, C. Cooksley, M. Chamber, et al., The burdens of cancer therapy. Clinical
and economic outcomes of chemotherapy-induced mucositis, Cancer 98 (2003)
1531–1539.
[7] S.T. Sonis, G. Oster, H. Fuchs, et al., Oral mucositis and the clinical and economic
outcomes of hematopoietic stem-cell transplantation, J. Clin. Oncol. 19 (2001)
2201–2205.
[8] A. Trotti, L.A. Bellm, J.B. Epstein, et al., Mucositis incidence, severity and asso-
ciated outcomes in patients with head and neck cancer receiving radiotherapy with
or without chemotherapy: a systematic literature review, Radiother. Oncol. 66
(2003) 253–262.
[9] M.A. Borilla, A.P. Gillio, M. Ruggeiro, et al., Effects of recombinant human gran-
ulocyte colony-stimulating factor on neutropenia in patients with congenital agra-
nulocytosis, N. Engl. J. Med. 370 (1989) 1574–1580.
[10] S.T. Sonis, Mucositis as a biological process: a new hypothesis for the development
of chemotherapy-induced stomatotoxicity, Oral Oncol. 34 (1998) 39–43.
[11] C.T. Viet, P.M. Corby, A. Akinwande, et al., Review of preclinical studies on
treatment of mucositis and associated pain, J. Dent. Res. 93 (2014) 868–875.
[12] S.T. Sonis, L.S. Elting, D. Keefe, et al., Perspectives on cancer therapy-induced
mucosal injury: pathogenesis, measurement, epidemiology, and consequences for
patients, Cancer 100 (2004) 1995–2025.
[13] S.T. Sonis, The pathobiology of mucositis, Nat. Rev. Cancer 4 (2004) 277–284.
[14] S.M. Benzen, M.I. Saunders, S. Dishche, et al., Radiotherapy-related early morbidity
in head and neck cancer: quantitative clinical radiobiology as deduced from the
CHART trial, Radiother. Oncol. 60 (2001) 123–135.
[15] D.M. Keefe, M.M. Schubert, L.S. Elting, et al., Updated clinical practice guidelines
for the prevention and treatment of mucositis, Cancer 109 (2007) 820–831.
[16] W. Bensinger, M. Schubert, K.K. Ang, et al., NCCN Task Force Report. Prevention
and management of mucositis in cancer care, J. Natl. Compr. Cancer Netw. 6 (2008)
S1–S21.
[17] S. Hayakumo, S. Arakawa, M. Takahashi, et al., Effects of ozone nano-bubble water
on periodontopathic bacteria and oral cells in vitro studies, Sci. Technol. Adv.
Mater. 15 (2014), https://doi.org/10.1088/1468-6996/15/5/05503.
[18] Y. Makita, Y. Imamura, K. Masuno, et al., The effect of ozone on collagen type-1 and
inflammatory cytokine production in human gingival fibroblasts, Dentistry 5 (2015)
339, https://doi.org/10.4172/2161-1122.1000339.
[19] D. Sakai, Y. Makita, K. Masuno, et al., Local hemostatic effect of aqueous ozone in
cutting wound surface, J. Hard Tissue Biol. 23 (2014) 245–248.
[20] K. Kamiyama, S. Arakawa, M. Takahashi, et al., Effects of nano-bubble water on
periodontal disease, Jpn. J. Undersea Hyper. Med. 43 (2008) 53–59.
[21] M. Kumar, Ozone Nano Bubble Water: a magic wand for the treatment of period-
ontal disease, ARC J. Dent. Sci. 1 (2016) 1–2.
[22] M.D. Vilela-Goulart, R.T. Teixeira, D.C. Rangel, et al., Homogenous amniotic
membrane as a biological dressing for oral mucositis in rats: histomorphometric
analysis, Arch. Oral Biol. 53 (2008) 1163–1171.
[23] S.T. Sonis, C. Tracey, G. Shklar, et al., An animal model for mucositis induced by
cancer chemotherapy, Oral Surg. Oral Med. Oral Pathol. 69 (1990) 437–443.
[24] National Cancer Institute, Common Terminology criteria for adverse events
(CTCAE), Available from: National Cancer Institute (US National Institutes of
Health) website: http://www.cancer.gov/ Nov 20,2018.
[25] R. Hamada, J. Suehiro, M. Nakano, et al., Development of rapid oral bacteria de-
tection apparatus based on dielectrophoretic impedance measurement method, IET
Nanobiotechnol. 5 (2011) 25–31.
[26] M. Funahara, S. Hayashida, Y. Sakamoto, et al., Efficacy of topical antibiotic ad-
ministration on the inhibition of perioperative oral bacterial growth in oral cancer
patients: a preliminary study, Int. J. Oral Maxillofac. Surg. 44 (2015) 1225–1230.
[27] M. Ikeda, T. Miki, M. Atsumi, et al., Effective elimination of contaminants after oral
care in elderly institutionalized individuals, Geriatr. Nurs. 35 (2014) 295–299.
[28] S. Guo, L.A. Dipietro, Factors affecting wound healing, J. Dent. Res. 89 (2010)
219–229.
[29] B. Healy, A. Freedman, ABC of wound healing, Infections, BMJ 332 (2006)
838–841.
[30] W.A. Altemeier, W.R. Culbertson, R.P. Hummel, Surgical considerations of en-
dogenous infections sources, types, and methods of control, Surg. Clin. N. Am. 48
(1968) 227–240.
[31] S. Hayashida, M. Funahara, M. Sekino, et al., The effect of tooth brushing, irriga-
tion, and topical tetracycline administration on the reduction of oral bacteria in
mechanically ventilated patients: a preliminary study, BMC Oral Health 16
(2016) 67.
[32] M. Funahara, S. Hyashida, Y. Sakamoto, et al., Efficacy of topical antibiotic ad-
ministration on the inhibition of perioperative oral bacterial growth in oral cancer
patients: a preliminary study, Int. J. Oral Maxillofac. Surg. 44 (2015) 1225–1230.
[33] B. Peterson, L. Sales, A. Winston, et al., Fabrication of customized tongue-displacing
stents: considerations for use in patients receiving head and neck radiotherapy, J.
Am. Dent. Assoc. 144 (2013) 594–600.
[34] N. Bergstrom, M.A. Bennett, C.E. Carlson, et al., Treatment of Pressure Ulcer:
Clinical Practice Guideline No.15. AHCPR Publication 95-0652, Agency for Health
Care Policy and Research, Public Health Service, US Department of Health and
Human Services, Rockville MD, 1994.
[35] A. Furuichi, S. Arakawa, Y. Mano, et al., Comparative analysis of efficacy of ozone
nano bubble water (NBW3) with established antimicrobials. Bactericidal efficacy
and cellular response. An in vitro study, J. Oral Tissue Eng. 10 (2013) 131–141.
[36] K. Yamashita, M. Ohara, T. Kojima, et al., Prevalence of drug-resistant opportunistic
microorganisms in oral cavity after treatment for oral cancer, J. Oral Sci. 55 (2013)
145–155.
[37] R.V. Lalla, J. Bowen, A. Barasch, et al., Mucositis guidelines leadership group of the
multinational association of supportive care in cancer and international society of
oral oncology (MASCC/ISOO), MASCC/ISOO clinical practice guidelines for the
management of mucositis secondary to cancer therapy, Cancer 120 (2014)
1453–1461.
K. Hayashi, et al. Biochemistry and Biophysics Reports 20 (2019) 100697
5
